Adverum Biotechnologies, Inc. (ADVM)
NASDAQ: ADVM · IEX Real-Time Price · USD
11.00
-0.34 (-3.00%)
At close: Apr 23, 2024, 4:00 PM
11.55
+0.55 (5.00%)
After-hours: Apr 23, 2024, 6:37 PM EDT

Adverum Biotechnologies Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2012
Revenue
3.607.500.251.611.851.462.320.57
Upgrade
Revenue Growth (YoY)
-----84.49%-12.82%27.08%-37.26%305.42%19.17%
Upgrade
Gross Profit
3.607.500.251.611.851.462.320.57
Upgrade
Selling, General & Admin
49.9257.8664.4444.6428.3824.5620.8624.3622.118
Upgrade
Research & Development
77.6899.2889.1873.3140.4250.1339.8431.6725.4616.98
Upgrade
Other Operating Expenses
000005060.712.570
Upgrade
Operating Expenses
127.59157.14153.62117.9568.879.6960.7116.7450.1424.97
Upgrade
Operating Income
-123.99-157.14-146.12-117.95-68.55-78.08-58.85-115.28-47.82-24.4
Upgrade
Interest Expense / Income
0000000000.02
Upgrade
Other Expense / Income
-5.75-2.67-0.58-1.56-4.06-4.2-2.7-0.76-0.370.98
Upgrade
Pretax Income
-118.24-154.46-145.54-116.39-64.49-73.88-56.15-114.52-47.45-25.4
Upgrade
Income Tax
-1.080.0701.110-1.250-0.7800
Upgrade
Net Income
-117.17-154.54-145.54-117.51-64.49-72.63-56.15-113.75-47.45-25.4
Upgrade
Preferred Dividends
0000000003.23
Upgrade
Net Income Common
-117.17-154.54-145.54-117.51-64.49-72.63-56.15-113.75-47.45-28.63
Upgrade
Shares Outstanding (Basic)
1010109664431
Upgrade
Shares Outstanding (Diluted)
1010109664431
Upgrade
Shares Change
1.58%1.24%15.14%32.83%4.44%40.57%20.46%42.26%118.69%217.21%
Upgrade
EPS (Basic)
-11.60-15.60-14.80-13.80-10.10-11.80-12.90-31.40-18.60-24.60
Upgrade
EPS (Diluted)
-11.60-15.60-14.80-13.80-10.10-11.80-12.90-31.40-18.60-24.60
Upgrade
Free Cash Flow
-91.71-119.91-122.95-91.14-68.42-54.77-46.44-40.78-38.33-6.59
Upgrade
Free Cash Flow Per Share
-9.10-12.08-12.54-10.70-10.67-8.92-10.64-11.25-15.04-5.66
Upgrade
Gross Margin
100.00%-100.00%-100.00%100.00%100.00%100.00%100.00%100.00%
Upgrade
Operating Margin
-3444.19%--1948.29%--27418.00%-4843.73%-3182.64%-7923.30%-2062.23%-4266.08%
Upgrade
Profit Margin
-3254.58%--1940.53%--25794.40%-4505.40%-3036.61%-7817.66%-2046.27%-5005.94%
Upgrade
Free Cash Flow Margin
-2547.50%--1639.39%--27366.80%-3397.83%-2511.47%-2802.61%-1652.87%-1152.27%
Upgrade
EBITDA
-99.57-143.89-140.9-112.24-62.91-72.13-54.05-112.92-46.64-25.22
Upgrade
EBITDA Margin
-2765.89%--1878.60%--25165.20%-4474.38%-2923.26%-7760.76%-2011.25%-4409.79%
Upgrade
Depreciation & Amortization
18.6710.574.654.161.571.752.11.60.810.16
Upgrade
EBIT
-118.24-154.46-145.54-116.39-64.49-73.88-56.15-114.52-47.45-25.39
Upgrade
EBIT Margin
-3284.53%--1940.53%--25794.40%-4582.94%-3036.61%-7870.93%-2046.27%-4438.11%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).